We are live on ! Find out more
AURA icon

Aura Biosciences
AURA

117 hedge funds and large institutions have $274M invested in Aura Biosciences in 2025 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 38 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 8

10% more funds holding

Funds holding: 106 → 117 (+11)

4.04% less ownership

Funds ownership: 83.14% → 79.11% (-4%)

11% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 38

14% less capital invested

Capital invested by funds: $319M → $274M (-$45.4M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
117
Holders Change
+11
Holders Change %
+10.38%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.02%
New
19
Increased
34
Reduced
38
Closed
8
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$4K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$2.57M
2
BlackRock
BlackRock
New York
+$920K
3
Bank of America
Bank of America
North Carolina
+$766K
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$489K
5
Citadel Advisors
Citadel Advisors
Florida
+$407K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$4.31M
2
SB
Samsara BioCapital
California
-$3.61M
3
LCS
Levin Capital Strategies
New York
-$3.51M
4
CP
Caligan Partners
New York
-$1.4M
5
DC
Decheng Capital
California
-$921K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
26
Wellington Management Group
Massachusetts
$768K +$81K +13,647 +11%
Goldman Sachs
27
Goldman Sachs
New York
$763K -$327K -55,017 -28%
Charles Schwab
28
Charles Schwab
California
$736K +$683 +115 +0.1%
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$625K +$489K +82,399 +256%
PIM
30
Platinum Investment Management
Australia
$610K -$140K -23,537 -17%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$588K +$72.4K +12,187 +13%
RCAP
32
Resolute Capital Asset Partners
Colorado
$496K – – –
PCM
33
Permanent Capital Management
Illinois
$413K -$427K -71,905 -49%
N
34
Nuveen
North Carolina
$394K – – –
Barclays
35
Barclays
United Kingdom
$378K +$25.9K +4,366 +7%
Citadel Advisors
36
Citadel Advisors
Florida
$374K +$407K +68,549 New
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$354K -$23.8K -4,003 -6%
XT
38
XTX Topco
Cayman Islands
$331K +$214K +36,006 +145%
TGAM
39
TBH Global Asset Management
Tennessee
$329K – – –
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$325K -$2.49K -419 -0.7%
Point72 Asset Management
41
Point72 Asset Management
Connecticut
$298K +$325K +54,692 New
ECM
42
ExodusPoint Capital Management
New York
$280K +$47.5K +7,998 +18%
PCM
43
Prelude Capital Management
New York
$273K – – –
Wells Fargo
44
Wells Fargo
California
$267K +$103K +17,342 +55%
Jane Street
45
Jane Street
New York
$258K +$85.1K +14,327 +43%
Walleye Capital
46
Walleye Capital
New York
$253K -$124K -20,925 -31%
TI
47
Trexquant Investment
Connecticut
$234K +$255K +42,998 New
Ameriprise
48
Ameriprise
Minnesota
$233K -$463K -77,898 -65%
AllianceBernstein
49
AllianceBernstein
Tennessee
$227K – – –
American Century Companies
50
American Century Companies
Missouri
$222K +$12.2K +2,051 +5%
1
2
3 4 5

AURA Hedge Fund Activity: Q4 2025 in Review

117 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q4 2025, worth a combined $274M — down 14% from $319M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new AURA positions and 8 closed out — a net gain of 11 holders — while 34 added to existing stakes and 38 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.57M. The largest seller was UBS Group, cutting an estimated $4.31M.

  • 117 institutional investors held Aura Biosciences (AURA) as of Q4 2025, up from 106 in Q3 2025.
  • Funds reported $274M of Aura Biosciences stock for Q4 2025, down 14% quarter-over-quarter.
  • 19 funds opened new Aura Biosciences positions in Q4 2025 and 8 closed out, a net change of +11 holders.
  • The largest Aura Biosciences buyer in Q4 2025 was Millennium Management, an estimated $2.57M added.
  • The largest Aura Biosciences seller in Q4 2025 was UBS Group, an estimated $4.31M sold.

Based on aggregated 13F filings for Q4 2025.